EORTC - European Organisation for Research and Treatment of Cancer

💡 Get ready to submit your Late Breaking Abstracts (LBA) for #ENASymp24! Showcase your cutting-edge research and breakthroughs in drug development, translational research, and molecular target validation. ❗ Submission opens on 18 September and closes on 25 September. Find out more 👉 https://lnkd.in/eZPhZZQz American Association for Cancer Research National Cancer Institute (NCI) #CancerResearch #ClinicalTrials #Oncology

📢 Don't miss out on our upcoming Multi-Stakeholder Workshop on "Innovation and Access in #RareCancers" with The Cancer Drug Development Forum (CDDF). This hybrid event takes place on 23-24 September 2024. Register now: https://lnkd.in/dkQGTdvR #CancerResearch #ClinicalTrials #Oncology

📚 Have you read our latest publication in The Lancet Oncology? Understanding patients’ health-related #qualityoflife after completion of an adjuvant treatment for #melanoma is important.  The research area concerns patients who are likely to become cancer survivors and would be impacted by potential long-term adverse effects. This publication provides results on the long-term health-related quality of life of melanoma patients treated with a PD-1 inhibitor.  Read more 👇  https://lnkd.in/eRbmjjsT #CancerResearch #ClinicalTrials #Oncology

🚀 Final opportunity for exhibition at #ENASymp24! Only 2 exhibition spaces left at ENA in Barcelona. Highlight your cutting-edge drug developments and connect with key leaders in oncology. Secure your spot today! Download the prospectus to explore the exhibition and other sponsorship opportunities: https://lnkd.in/e7i2iJmA American Association for Cancer Research National Cancer Institute (NCI) Rosa Ciloglu #CancerResearch #ClinicalTrials #Oncology

🌟 Join us at the 34th EORTC-NCI-AACR (ENA) Molecular Targets and Cancer Therapeutics Symposium on 23-25 October 2024 in Barcelona! This prestigious meeting unites laboratory specialists, translational research experts, drug developers, physicians, and methodologists to promote collaboration and understanding between the various disciplines relevant to drug development, translational research, and molecular target validation. Come and be part of this community and benefit from the many insights and networking opportunities it offers. Register now 👉 https://lnkd.in/evPz4x2i American Association for Cancer Research, National Cancer Institute (NCI) #ENASymp24 #CancerResearch #ClinicalTrials #Oncology

📚 We are excited to share a new publication about the E2-RADIatE #OligoCare cohort, the largest prospective registry cohort on oligometastatic disease. This interim analysis of approximately 1600 oligometastatic patients aimed to evaluate acute toxicity within 6 months following stereotactic body radiotherapy (SBRT). Toxicity within 6 months was low, confirming that SBRT is safe to use in the oligometastatic setting. View the publication: https://lnkd.in/easnTr8Z #CancerResearch #ClinicalTrials #Oncology #E2RADIatE #SBRT

🎙️ Roger Wilson is a sarcoma patient and the founder of Sarcoma UK one of EORTC’s funding partners of the STRASS/STREXIT 2 clinical trial. He is also the Honorary President and an active Board member of the Sarcoma Patient Advocacy Global Network (SPAGN).   Learn more about his story and involvement in the EORTC-lead STREXIT 2 Project in this insightful interview: https://lnkd.in/d58SrRHv Climbers Against Cancer, Cancer Research UK (CRUK), Novo Nordisk Foundation, Syreon Research Institute #STREXIT2_Horizon #HorizonEurope #EUCancerMission #CancerResearch #PragmaticClinicalTrials #ClinicalTrials #Oncology #RetroperitonealSarcoma #sarcomaawarenessmonth2024

📚 We are proud to share a new EORTC #publication describing the RP-2321-GITCG ASPIRE study protocol. ASPIRE is the first global study evaluating the interchangeability of programmed death-ligand 1 (PD-L1) scoring systems and assays in gastro-esophageal cancer. Read the publication: https://lnkd.in/duYgBRub #CancerResearch #ClinicalTrials #Oncology #gastroesophagealcancer #StomachCancer

📢 Are you a recently specialised radiation or medical oncologist passionate about clinical cancer research and radiotherapy? The EORTC, in collaboration with the Emmanuel van der Schueren fellowship programme supported by Kom Op Tegen Kanker, is offering a one-year fellowship focused on radiotherapy quality assurance in clinical trials. 🚀 Apply now: https://lnkd.in/dr34gBTU #CancerResearch #WorkWithUs #Vacancy #Jobs #Radiotherapy #RTQA

📢 Join the EORTC HQ team in Brussels for one-year and become our next #QualityOfLife research fellow. This position is focused on patient-reported outcomes in #cancer #ClinicalTrials. Do you have both qualitative research skills and experience with quantitative research methods? Apply now: https://lnkd.in/g8nzVT8n #Oncology #EORTCfellowship #Fellowship #WorkWithUs #Vacancy #ResearchFellowship #CancerResearch #PROs